On April 4, 2018, Versant Ventures, a global healthcare investment firm, announced that Roche Holdings has acquired a program known as Inception 5, which is focused on regenerative therapies for multiple sclerosis (MS). Financial terms of the deal were not disclosed.
According to Versant,Original Article
